NCT01799850View on ClinicalTrials.gov

The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

March 31, 2004

Study Completion Date

March 31, 2004

Conditions
Diabetes Type 2
Interventions
DRUG

Pioglitazone

pioglitazone 30 mg daily, pill, eight weeks, placebo randomly assigned

DRUG

placebo

placebo assigned randomly, double blind

Trial Locations (1)

37614

ETSU Quillen College of Medicine, Johnson City

All Listed Sponsors
collaborator

Takeda Pharmaceuticals North America, Inc.

INDUSTRY

lead

East Tennessee State University

OTHER

NCT01799850 - The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle | Biotech Hunter | Biotech Hunter